{"product_id":"acc-21-congress-american-college","title":"ACC.21 Congress (American College of Cardiology 2021 Congress) (Videos)","description":"\u003ch3\u003eACC.21 Congress (American College of Cardiology 2021 Congress)\u003c\/h3\u003e\n\u003cheader\u003e\u003c\/header\u003e\u003cheader\u003e\u003cstrong\u003e\u003cspan class=\"save format-btn\"\u003eACC.21 Congress (American College of Cardiology 2021 Congress) (Videos) 297 high quality videos (TS)\u003c\/span\u003e\u003c\/strong\u003e\u003cstrong\u003e\u003cspan class=\"save format-btn\"\u003eFile Size = 102.00 GB\u003c\/span\u003e\u003c\/strong\u003e\u003cstrong\u003e*American College of Cardiology 2021 Congress*\u003c\/strong\u003e\u003cem\u003eACC.21\u003c\/em\u003e, the All Virtual Experience, will feature late-breaking clinical research and education across 11 learning pathways in an engaging and interactive forum providing the latest practice-changing updates in care.\u003c\/header\u003e\n\u003cul\u003e\n\u003cli\u003eFrom May 15 – 17, \u003cem\u003eACC.21\u003c\/em\u003e streamed to thousands of members of the cardiovascular team from around the world! Take time to explore ALL the education from ACC.21 with On Demand access.\u003c\/li\u003e\n\u003cli\u003eWatch 300+ sessions featuring practice-changing research and cutting-edge education. Plus, don’t miss the more than 3,3000 eAbstracts, 100+ exhibitors, and the opportunity to celebrate the achievements of our colleagues with Convocation. Sample from an unparalleled array of education when it’s convenient for you — from your home, office, or on-the-go — across 11 learning pathways. ACC.21 will leave you up to date on the newest clinical research and you’ll find out how it all impacts the care of your patients.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cimg alt=\"\" class=\"alignnone size-full wp-image-11334\" height=\"1024\" src=\"https:\/\/medical-amboss.com\/wp-content\/uploads\/2023\/07\/ACC.21-Congress.jpg\" width=\"768\"\u003e\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003ch4\u003e*Contents: (297 videos)\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e| 406 Joint American College of CardiologyJournal of the American Medical Association Late-Breaking Clinical Trials.ts\u003c\/li\u003e\n\u003cli\u003e| 407 Joint American College of CardiologyNew England Journal of Medicine Late-Breaking Clinical Trials.ts\u003c\/li\u003e\n\u003cli\u003e| 411 Late-Breaking Clinical Trials V.ts\u003c\/li\u003e\n\u003cli\u003e| 908 Highlighted Original Research Multimodality Imaging and the Year in Review.ts\u003c\/li\u003e\n\u003cli\u003e| 910 Highlighted Original Research Ischemic Heart Disease and the Year in Review.ts\u003c\/li\u003e\n\u003cli\u003e| A Contemporary Understanding of the Diagnosis and Management of Low Flow Low Gradient Severe Aortic Stenosis.ts\u003c\/li\u003e\n\u003cli\u003e| A Melting Pot of Clinical Valvular Heart Disease Cases No Cookbook, but a Practical Applications from the Valve Guidelines.ts\u003c\/li\u003e\n\u003cli\u003e| A Practical Approach to Shared Decision Making when Treating Heart Valve Disease.ts\u003c\/li\u003e\n\u003cli\u003e| A Review of the RADIANCE-HTN Global Clinical Trial Program A Focus on the TRIO cohort.ts\u003c\/li\u003e\n\u003cli\u003e| ACC Cardiology Hour.ts\u003c\/li\u003e\n\u003cli\u003e| ACC.21 Highlights in Hypertension.ts\u003c\/li\u003e\n\u003cli\u003e| ACC21-Frequently-Asked-Questions-UPLOADED-May-11-2021.pdf\u003c\/li\u003e\n\u003cli\u003e| Acing the Transition What FITs Need to Know to Launch a Healthy, Successful Career.ts\u003c\/li\u003e\n\u003cli\u003e| Adult Congenital Heart Disease Cases That Stumped Me.ts\u003c\/li\u003e\n\u003cli\u003e| Advanced Nuclear Cardiology Applications in 2021.ts\u003c\/li\u003e\n\u003cli\u003e| Advances and new studies for the treatment of MR with Abbott’s TMV repair and replacement therapies.ts\u003c\/li\u003e\n\u003cli\u003e| Advancing Patient Care Across the Heart Failure Continuum.ts\u003c\/li\u003e\n\u003cli\u003e| Advancing Systems of Care in STEMI, Stroke, Cardiac Arrest, Shock.ts\u003c\/li\u003e\n\u003cli\u003e| Anticoagulation Trivia from A to V Management Strategies Across the Board Meeting on Demand.mp4\u003c\/li\u003e\n\u003cli\u003e| Antithrombotic Controversies in the Cath Lab.ts\u003c\/li\u003e\n\u003cli\u003e| Antithrombotic Management in Patients with Atrial Fibrillation Undergoing PCI.ts\u003c\/li\u003e\n\u003cli\u003e| Aortic Valve Interventions Clinical Dilemmas.ts\u003c\/li\u003e\n\u003cli\u003e| Aortic Valve Interventions Expanding Indications.ts\u003c\/li\u003e\n\u003cli\u003e| Application of Dual Source CT in cardiac imaging – a focus on Structural Heart Disease.ts\u003c\/li\u003e\n\u003cli\u003e| Applying the Guidelines For Lipid Management in Special Populations.ts\u003c\/li\u003e\n\u003cli\u003e| Arrhythmogenic Cardiomyopathies Tell Me What I Need to Know.ts\u003c\/li\u003e\n\u003cli\u003e| ASCVD Risk Factors and Beyond.ts\u003c\/li\u003e\n\u003cli\u003e| Atrial Fibrillation Management in Athletes.ts\u003c\/li\u003e\n\u003cli\u003e| Best of JACC Journals \u0026amp; Eugene Braunwald Keynote.ts\u003c\/li\u003e\n\u003cli\u003e| Best Practices of Multimodality Imaging in Percutaneous Mitral Interventions.ts\u003c\/li\u003e\n\u003cli\u003e| Beyond a Broken Heart Multisystem Disease Burden in hATTR Amyloidosis.ts\u003c\/li\u003e\n\u003cli\u003e| Beyond Atrial Fibrillation – Atrial Cardiopathy as a Cause of Cryptogenic Stroke.ts\u003c\/li\u003e\n\u003cli\u003e| Bleeding Reduction Strategies Following PCI.ts\u003c\/li\u003e\n\u003cli\u003e| Breakthrough Transcatheter Pulmonary Valve Treatment Option for Adult and Pediatric CHD Patients.ts\u003c\/li\u003e\n\u003cli\u003e| Cardiac CT in Clinical Practice.ts\u003c\/li\u003e\n\u003cli\u003e| Cardiac Culture Medium Current Concepts in Infective Endocarditis.ts\u003c\/li\u003e\n\u003cli\u003e| Cardiac Imaging in Older Adults Overused or Underutilized Practical Points for Clinicians.ts\u003c\/li\u003e\n\u003cli\u003e| Cardiac Point of Care Ultrasound Around the World.ts\u003c\/li\u003e\n\u003cli\u003e| Cardiac Rehab Move to Improve.ts\u003c\/li\u003e\n\u003cli\u003e| Cardio-Oncology Today’s Standard of Practice.ts\u003c\/li\u003e\n\u003cli\u003e| Cardiogenic Shock Progress, Paradigms and Unresolved Problems.ts\u003c\/li\u003e\n\u003cli\u003e| Cardiogenic Shock Teams and Devices for Cardiogenic Shock.ts\u003c\/li\u003e\n\u003cli\u003e| Cardiologist Versus Calcium Unstoppable Force Meets Immovable Object.ts\u003c\/li\u003e\n\u003cli\u003e| Cardiovascular Considerations in Amateur and Professional Athletes.ts\u003c\/li\u003e\n\u003cli\u003e| Cardiovascular Imaging For Diagnosis And Management of Coronary Microvascular Disease.ts\u003c\/li\u003e\n\u003cli\u003e| Cardiovascular Imaging to Enhance Prevention.ts\u003c\/li\u003e\n\u003cli\u003e| Caring for the Patient with STEMI in 2021.ts\u003c\/li\u003e\n\u003cli\u003e| Case Based Learning for the Cardiovascular Team.ts\u003c\/li\u003e\n\u003cli\u003e| Cases from the Guidelines for Clinicians.ts\u003c\/li\u003e\n\u003cli\u003e| CCM® Therapy – A Device Based Approach for the Treatment of Heart Failure.ts\u003c\/li\u003e\n\u003cli\u003e| Challenges of Transplantation in Congenital Heart Disease Patients Ethics, Listing Strategy \u0026amp; MCS.ts\u003c\/li\u003e\n\u003cli\u003e| Challenging Cases in Cardio-Oncology.ts\u003c\/li\u003e\n\u003cli\u003e| Chest Pain Evaluation in 2021 Same Problem, New Tools, New Questions.ts\u003c\/li\u003e\n\u003cli\u003e| Clarity From Confusion in Heart Failure With Preserved Ejection Fraction (HFpEF).ts\u003c\/li\u003e\n\u003cli\u003e| Clinical Trials Research Upping Your Game.ts\u003c\/li\u003e\n\u003cli\u003e| Clinical Trials ThunderDome Who Will Be Crowned Most Impactful.ts\u003c\/li\u003e\n\u003cli\u003e| Complex and High-Risk PCI Case Based Joint Symposium.ts\u003c\/li\u003e\n\u003cli\u003e| Complex Case-Based Decision-Making – The Heart Team in Action A Joint Symposium by TCT.ts\u003c\/li\u003e\n\u003cli\u003e| Complex Dilemmas in Valvular Heart Disease.ts\u003c\/li\u003e\n\u003cli\u003e| Contemporary Aortic Valve Disease Management.ts\u003c\/li\u003e\n\u003cli\u003e| Contemporary Challenges in Cardiac Critical Care Structure, Staffing, Training and Beyond.ts\u003c\/li\u003e\n\u003cli\u003e| Controversial Topics in Cardiac Transplantation and Ventricular Assist Devices.ts\u003c\/li\u003e\n\u003cli\u003e| Controversies in Arrhythmia Therapy.ts\u003c\/li\u003e\n\u003cli\u003e| Controversies in Interventional and Surgical Management of Congenital Heart Disease.ts\u003c\/li\u003e\n\u003cli\u003e| Controversies in the ICU Management of Congenital Heart Disease.ts\u003c\/li\u003e\n\u003cli\u003e| Core Knowledge in Action Essentials of Stable Ischemic Heart Disease.ts\u003c\/li\u003e\n\u003cli\u003e| Core Knowledge in Action Return to the Basics of Aortic Stenosis.ts\u003c\/li\u003e\n\u003cli\u003e| Core Knowledge in Action The Ultimate Guide to Lipids.ts\u003c\/li\u003e\n\u003cli\u003e| Core Knowledge in Action What Everyone Ought To Know About HFpEF.ts\u003c\/li\u003e\n\u003cli\u003e| Coronary Artery Disease – Atherogenesis, Acute Coronary Syndromes and Stroke.ts\u003c\/li\u003e\n\u003cli\u003e| Coronary IVL’s Who, What, Where, When \u0026amp; Why An Introductory Guide for Clinical Practice.ts\u003c\/li\u003e\n\u003cli\u003e| COVID 19 and Heart Failure Lessons Learned and Future Directions.ts\u003c\/li\u003e\n\u003cli\u003e| COVID-19 and Echocardiography – Impact, Imaging, and Innovation.ts\u003c\/li\u003e\n\u003cli\u003e| Critical Clinical Conundrums in Acute Coronary Syndromes.ts\u003c\/li\u003e\n\u003cli\u003e| Current Approaches to Antiplatelet Therapy for PCI in Acute Coronary Syndrome.ts\u003c\/li\u003e\n\u003cli\u003e| Current Controversies And Debates in CAD Imaging.ts\u003c\/li\u003e\n\u003cli\u003e| CVD Prevention in the Post-COVID19 Era2.ts\u003c\/li\u003e\n\u003cli\u003e| Debates in Arrhythmia Management in Congenital Heart Disease.ts\u003c\/li\u003e\n\u003cli\u003e| Debates Should We Tailor Antiplatelet Therapy for PCI.ts\u003c\/li\u003e\n\u003cli\u003e| Debating Controversies in STEMI Care.ts\u003c\/li\u003e\n\u003cli\u003e| Deep Dive I.ts\u003c\/li\u003e\n\u003cli\u003e| Deep Dive II.ts\u003c\/li\u003e\n\u003cli\u003e| Destined to Fail How to Prevent Heart Failure.ts\u003c\/li\u003e\n\u003cli\u003e| Diabesity A Tale of Obesity, Inflammation and Cardiometabolic Risk.ts\u003c\/li\u003e\n\u003cli\u003e| Diabetes and Heart Failure.ts\u003c\/li\u003e\n\u003cli\u003e| Diagnostic Testing in Stable Ischemic Heart Disease Choosing Wisely.ts\u003c\/li\u003e\n\u003cli\u003e| Disparities and the Role of Social Determinants of Health in Acute and Stable Ischemic Heart Disease.ts\u003c\/li\u003e\n\u003cli\u003e| Dissecting the Data Discussions on the Management of SCAD.ts\u003c\/li\u003e\n\u003cli\u003e| Doorways To The Heart Valves In Systemic Disease.ts\u003c\/li\u003e\n\u003cli\u003e| Drug Jeopardy Pharmacological Conundrums in Arrhythmia Management.ts\u003c\/li\u003e\n\u003cli\u003e| ECGs With the Experts Practical Considerations For the Cardiovascular Clinician.ts\u003c\/li\u003e\n\u003cli\u003e| Electrical Disorders – Rhythm and Conduction Disorders.ts\u003c\/li\u003e\n\u003cli\u003e| Emerging Technologies in Vascular Disease.ts\u003c\/li\u003e\n\u003cli\u003e| Endovascular Skills Basics to Bailout Techniques.ts\u003c\/li\u003e\n\u003cli\u003e| EP Issues in Cancer Patients – Beyond Heart Failure.ts\u003c\/li\u003e\n\u003cli\u003e| Essential Vascular Pearls for the Cardiovascular Clinician.ts\u003c\/li\u003e\n\u003cli\u003e| Essentials of Atrial Fibrillation Management – Learn From the Experts.ts\u003c\/li\u003e\n\u003cli\u003e| Evolution of Aortic Valve Replacement in Low-Risk Patients.ts\u003c\/li\u003e\n\u003cli\u003e| Expanding Frontiers in Vascular Intervention.ts\u003c\/li\u003e\n\u003cli\u003e| Expanding the Toolkit Tackling Residual Atherogenic Lipid Risk.ts\u003c\/li\u003e\n\u003cli\u003e| Exploring New Synergies Integrating a Cardiac CT Scanner and Interventional C-arm in our Cath Lab.ts\u003c\/li\u003e\n\u003cli\u003e| Featured Clinical Research I.ts\u003c\/li\u003e\n\u003cli\u003e| Featured Clinical Research II.ts\u003c\/li\u003e\n\u003cli\u003e| Featured Clinical Research III.ts\u003c\/li\u003e\n\u003cli\u003e| Fellows Bootcamp Coronary and Peripheral Disease Management – The Best Cases You Have Seen Yet.ts\u003c\/li\u003e\n\u003cli\u003e| Fellows Bootcamp Structural.ts\u003c\/li\u003e\n\u003cli\u003e| FIT Forum Stump the Professor.ts\u003c\/li\u003e\n\u003cli\u003e| FIT Jeopardy Battle of the State Chapters Finals.ts\u003c\/li\u003e\n\u003cli\u003e| Focus on Interventional Complications.ts\u003c\/li\u003e\n\u003cli\u003e| Four Models of Myocardial Disease \u0026amp; Heart Failure – Myocarditis, HFrEF, HFpEF, HCM.ts\u003c\/li\u003e\n\u003cli\u003e| From Controversy to Clarity in Weight Loss Therapies.ts\u003c\/li\u003e\n\u003cli\u003e| Fusion imaging for transcatheter edge-to-edge mitral valve repair.ts\u003c\/li\u003e\n\u003cli\u003e| Gender-Specific Care of Patients with Acute Coronary Syndrome.ts\u003c\/li\u003e\n\u003cli\u003e| Genetics through Geriatrics – CV Prevention Through the Lifespan.ts\u003c\/li\u003e\n\u003cli\u003e| Getting to the Root of Dietary Effects.ts\u003c\/li\u003e\n\u003cli\u003e| Getting Your Life-and-Style Back in CVD.ts\u003c\/li\u003e\n\u003cli\u003e| Global Burden of Cardiovascular Disease in Women.ts\u003c\/li\u003e\n\u003cli\u003e| Global Leadership and Professional Education in the COVID-19 Era.ts\u003c\/li\u003e\n\u003cli\u003e| Great Debates in Vascular Medicine.ts\u003c\/li\u003e\n\u003cli\u003e| Harnessing the Power of Technology Remote Monitoring and Management in HF.ts\u003c\/li\u003e\n\u003cli\u003e| Help LDL.ts\u003c\/li\u003e\n\u003cli\u003e| Help Your Recent MI Patients Achieve Lower LDL-C and Reduce the Risk of Another MI (2).ts\u003c\/li\u003e\n\u003cli\u003e| Help Your Recent MI Patients Achieve Lower LDL-C and Reduce the Risk of Another MI.ts\u003c\/li\u003e\n\u003cli\u003e| Hemodynamics of Heart Failure You Thought You Knew Them.ts\u003c\/li\u003e\n\u003cli\u003e| Heterotaxy Syndrome or Somerism Whose Side Are You On.ts\u003c\/li\u003e\n\u003cli\u003e| Highlighted Original Research Electrophysiology and the Year in Review.ts\u003c\/li\u003e\n\u003cli\u003e| Highlighted Original Research Heart Failure and Cardiomyopathies and the Year in Review.ts\u003c\/li\u003e\n\u003cli\u003e| Highlighted Original Research Interventional and Structural and the Year in Review.ts\u003c\/li\u003e\n\u003cli\u003e| Highlighted Original Research Pediatric and Congenital Heart Disease and the Year in Review.ts\u003c\/li\u003e\n\u003cli\u003e| Highlighted Original Research Prevention and Health Promotion and the Year in Review.ts\u003c\/li\u003e\n\u003cli\u003e| Highlighted Original Research Pulmonary Vascular Disease and the Year in Review.ts\u003c\/li\u003e\n\u003cli\u003e| Highlighted Original Research Valvular Heart Disease and the Year in Review.ts\u003c\/li\u003e\n\u003cli\u003e| Highlighted Original Research Vascular Medicine and the Year in Review.ts\u003c\/li\u003e\n\u003cli\u003e| Holy Estrogen! Sex Disparities in Heart Failure Therapies Biology, Bias or Both.ts\u003c\/li\u003e\n\u003cli\u003e| How Can I Tell If This Aortic Valve Replacement Is Functioning Normally.ts\u003c\/li\u003e\n\u003cli\u003e| How does Paradise Renal Denervation Fit Into Hypertension Treatment Management.ts\u003c\/li\u003e\n\u003cli\u003e| How Much is Too Much Navigating Medication Overload by Medication Deprescribing.ts\u003c\/li\u003e\n\u003cli\u003e| How to be an Effective Mentor \u0026amp; Mentee.ts\u003c\/li\u003e\n\u003cli\u003e| How to Become a Successful Researcher at Every Stage of Your Career.ts\u003c\/li\u003e\n\u003cli\u003e| How to Choose and Optimize Pacing in Patients with Heart Failure Conduction System Pacing and CRT.ts\u003c\/li\u003e\n\u003cli\u003e| How to Deal With Cases That Go From No Problem to Nightmare.ts\u003c\/li\u003e\n\u003cli\u003e| How to Stent a LM Like a Boss Left Main PCI Workshop.ts\u003c\/li\u003e\n\u003cli\u003e| Hypertension Guidelines Do They Vary Across the World as Much as My Blood Pressure Has Today .ts\u003c\/li\u003e\n\u003cli\u003e| Hypertension Management A Future Full of Promises.ts\u003c\/li\u003e\n\u003cli\u003e| I Know the Evidence So How Do I Incorporate Nutrition and Lifestyle in My Clinic.ts\u003c\/li\u003e\n\u003cli\u003e| Imagination is Everything Innovations in the Cath Lab.ts\u003c\/li\u003e\n\u003cli\u003e| Imaging Cardiomyopathies Challenging Cases.ts\u003c\/li\u003e\n\u003cli\u003e| Imaging Decision Making in Everyday Clinical Practice for Coronary Artery Disease.ts\u003c\/li\u003e\n\u003cli\u003e| Imaging of Congenital Heart Disease Seeing Things We Never Saw Before.ts\u003c\/li\u003e\n\u003cli\u003e| Implementing Rhythm Control Guidelines in Atrial Fibrillation The Good, The Bad, and The Ugly.ts\u003c\/li\u003e\n\u003cli\u003e| Indirect Valvular Heart Disease Problems and Perspectives.ts\u003c\/li\u003e\n\u003cli\u003e| Innovative Nutritional and Dietary Approaches for Cardiometabolic Disease.ts\u003c\/li\u003e\n\u003cli\u003e| Insight of BAV Disease from Asia and Western Perspectives.ts\u003c\/li\u003e\n\u003cli\u003e| International Centers of Excellence Todays Solutions for an Improved Tomorrow.ts\u003c\/li\u003e\n\u003cli\u003e| Interventional Challenging Cases II An Interventional \u0026amp; SHD Potpourri Not to Miss.ts\u003c\/li\u003e\n\u003cli\u003e| Interventional Challenging Cases Will Make You Think.ts\u003c\/li\u003e\n\u003cli\u003e| Invasive Imaging and Physiology Diagnosis and Management of ACS Patients and Plaques.ts\u003c\/li\u003e\n\u003cli\u003e| Is the Quality of Cardiovascular Research Declining What Research Should Continue to be Pursued.ts\u003c\/li\u003e\n\u003cli\u003e| Jardiance® (empagliflozin) tablets The Impact of EMPA-REG OUTCOME.ts\u003c\/li\u003e\n\u003cli\u003e| Jeopardy.ts\u003c\/li\u003e\n\u003cli\u003e| Journey of the Right Ventricle in Pulmonary Hypertension.ts\u003c\/li\u003e\n\u003cli\u003e| Kick Starting Your Research Career.ts\u003c\/li\u003e\n\u003cli\u003e| Late-Breaking Clinical Trials IV.ts\u003c\/li\u003e\n\u003cli\u003e| Late-Breaking Clinical Trials.ts\u003c\/li\u003e\n\u003cli\u003e| Launching a Successful Career in Academic Cardiology Key Points to Success.ts\u003c\/li\u003e\n\u003cli\u003e| Left Atrial Appendage Occlusion Clinical Challenges.ts\u003c\/li\u003e\n\u003cli\u003e| Left Ventricular Ejection Fraction Past, Present, and Future Role in Heart Failure Care.ts\u003c\/li\u003e\n\u003cli\u003e| Let’s Get Physical! Exercise and Cardiovascular Health.ts\u003c\/li\u003e\n\u003cli\u003e| Lifelong Impact of Cardiovascular Risk Factors in Patients with Congenital Heart Disease.ts\u003c\/li\u003e\n\u003cli\u003e| Living in 3D.ts\u003c\/li\u003e\n\u003cli\u003e| Lower Extremity PAD Diagnostic Dilemmas, Disparities, and Patient Centered Outcomes.ts\u003c\/li\u003e\n\u003cli\u003e| Management of Pediatric Cardiology and Cardiac Surgery in the Post-COVID World.ts\u003c\/li\u003e\n\u003cli\u003e| Managing the Device Patient in 2021 From Cybersecurity, to MRI and Beyond.ts\u003c\/li\u003e\n\u003cli\u003e| Managing Today’s Advanced Heart Failure Patient.ts\u003c\/li\u003e\n\u003cli\u003e| Men Are From Mars, Women Are From Venus Sex-Specific Risk Factors That Enhance CVD Risk.ts\u003c\/li\u003e\n\u003cli\u003e| Minimally Invasive Therapies and Devices in AHF Featuring the 2021.ts\u003c\/li\u003e\n\u003cli\u003e| MINOCA A Show and Tell With the Experts.ts\u003c\/li\u003e\n\u003cli\u003e| Mitral Valve Disease and Cardiac Arrest Innocent Bystander or Guilty As Charged.ts\u003c\/li\u003e\n\u003cli\u003e| Mitral Valve Interventions Percutaneous Mitral Valve Repair.ts\u003c\/li\u003e\n\u003cli\u003e| Mobile ECG Monitoring How Can We Utilize Wearable Data.ts\u003c\/li\u003e\n\u003cli\u003e| Multimodality Cardiac Imaging and Modern Media.ts\u003c\/li\u003e\n\u003cli\u003e| Multimodality Imaging in Cardio-Oncology.ts\u003c\/li\u003e\n\u003cli\u003e| Multimodality Imaging in Challenging Cases of Infective Endocarditis.ts\u003c\/li\u003e\n\u003cli\u003e| Multimodality Imaging of Athletes What Do The New Consensus Statement Teach Us.ts\u003c\/li\u003e\n\u003cli\u003e| Must Know Tips for Publishing in JACC Journals.ts\u003c\/li\u003e\n\u003cli\u003e| Myocarditis and Heart Failure.ts\u003c\/li\u003e\n\u003cli\u003e| New AHAACC Valve Guidelines A Paradigm Shift in Management of Severe Aortic Stenosis.ts\u003c\/li\u003e\n\u003cli\u003e| New and Emerging Breakthrough Medicines for HFrEF! Now What Do We Do.ts\u003c\/li\u003e\n\u003cli\u003e| New Hypertension Therapies in Asian People.ts\u003c\/li\u003e\n\u003cli\u003e| New Innovations in Cardiovascular Imaging Incorporating Artificial Intelligence Into Daily Practice.ts\u003c\/li\u003e\n\u003cli\u003e| New Recommendations on How to Monitor Patients Post TAVRSAVR.ts\u003c\/li\u003e\n\u003cli\u003e| Nuts \u0026amp; Bolts of Pregnancy and Congenital Heart Disease.ts\u003c\/li\u003e\n\u003cli\u003e| Obstructive Sleep Apnea and Cardiovascular Outcomes What do Cardiologists Need to Know.ts\u003c\/li\u003e\n\u003cli\u003e| Off-Beat Topics in Heart Failure Improving Dysfunction By Treating the Rhythm.ts\u003c\/li\u003e\n\u003cli\u003e| Optimizing LDL-C Management in Recent MI Patients A Focus on Multidisciplinary Care Team Approach.ts\u003c\/li\u003e\n\u003cli\u003e| Optimizing the Patient Care Pathway and LDL-C Management in Patients with Recent MI.ts\u003c\/li\u003e\n\u003cli\u003e| Overcoming Therapeutic Inertia Maximizing Guideline Driven Medical Therapy in Heart Failure.ts\u003c\/li\u003e\n\u003cli\u003e| Parenteral Antithrombotic Therapies for ACS and PCI.ts\u003c\/li\u003e\n\u003cli\u003e| PCI in patients with CKD Insights from a nephrology and interventional cardiology partnership.ts\u003c\/li\u003e\n\u003cli\u003e| Perlas practicas en manejo de lipidos.ts\u003c\/li\u003e\n\u003cli\u003e| Perspectives on Pulmonary Hypertension.ts\u003c\/li\u003e\n\u003cli\u003e| Pharmacologic and Lifestyle Management for ISHD Why Disparities in Care Matter.ts\u003c\/li\u003e\n\u003cli\u003e| Pharmacology I Expanding the Cardiovascular Pharmacology Toolbox.ts\u003c\/li\u003e\n\u003cli\u003e| Pharmacology II Tackling the Supersized Epidemic of Cardio-diabetes.ts\u003c\/li\u003e\n\u003cli\u003e| Pharmacology III An Ounce of Prevention is Worth a Pound of Cure – Advances in Cardio-Oncology.ts\u003c\/li\u003e\n\u003cli\u003e| Pharmacotherapy Considerations in Cardio-Obstetrics.ts\u003c\/li\u003e\n\u003cli\u003e| Polite Parlays in Pulmonary Hypertension.ts\u003c\/li\u003e\n\u003cli\u003e| Potential Mechanisms Responsible for the Effects of Incretins on Atherosclerosis.ts\u003c\/li\u003e\n\u003cli\u003e| Practical Pearls on ASCVD and Lipid Management.ts\u003c\/li\u003e\n\u003cli\u003e| Pre-operative Care for Non-Cardiac Surgery Emerging Strategies and Ongoing Controversies.ts\u003c\/li\u003e\n\u003cli\u003e| Precision in Classification and Treatment of Heart Failure One Size Does Not Fit All.ts\u003c\/li\u003e\n\u003cli\u003e| Precision PCI in the Real World What Do I Use Every Day.ts\u003c\/li\u003e\n\u003cli\u003e| Proarrhythmia Look Outs! From the ICU to the Food We Eat.ts\u003c\/li\u003e\n\u003cli\u003e| Professional Advancement Across the Academic Cardiology Life Course.ts\u003c\/li\u003e\n\u003cli\u003e| Professionalism and Ethics in Cardiology.ts\u003c\/li\u003e\n\u003cli\u003e| Progression of Pulmonary Arterial Hypertension Pharmacotherapy Plainly Played-out in a Patient Case.ts\u003c\/li\u003e\n\u003cli\u003e| Protected PCI Diagnosis and Treatment of High-Risk and Complex Coronary Disease for Superior Long-term Outcomes.ts\u003c\/li\u003e\n\u003cli\u003e| Pulmonary Hypertension Primer WHO Are the Groups.ts\u003c\/li\u003e\n\u003cli\u003e| Raising the Clinical Suspicion for Hypertrophic Cardiomyopathy.ts\u003c\/li\u003e\n\u003cli\u003e| Rapid Fire Session on Valvular Heart Disease.ts\u003c\/li\u003e\n\u003cli\u003e| Re-imagining the 90-Day High-Risk Period Post-AMI Expert Discussions on Cholesterol Efflux and ApoA-I in Plaque Stabilization.ts\u003c\/li\u003e\n\u003cli\u003e| Recent Trials in SIHD Translating Results into Clinical Practice.ts\u003c\/li\u003e\n\u003cli\u003e| Registries in Cardiac Imaging How Will they Change Clinical Practice.ts\u003c\/li\u003e\n\u003cli\u003e| Repair Is Not Correction Long Term Follow-up of Surgery for Congenital Heart Disease.ts\u003c\/li\u003e\n\u003cli\u003e| Return To Play What The Experts Would Do.ts\u003c\/li\u003e\n\u003cli\u003e| Reversible Cardiomyopathies Arrhythmias, Pacing, Dyssynchrony and Inflammation.ts\u003c\/li\u003e\n\u003cli\u003e| Right Sided Valve Interventions.ts\u003c\/li\u003e\n\u003cli\u003e| Role of Multimodality Imaging in Diagnosis and Management of Cardiovascular Complications in Patients with COVID-19.ts\u003c\/li\u003e\n\u003cli\u003e| Sex Differences in Arrhythmias.ts\u003c\/li\u003e\n\u003cli\u003e| Shock Teams and Shock Docs.ts\u003c\/li\u003e\n\u003cli\u003e| So You Want To Be a Chief of Cardiology.ts\u003c\/li\u003e\n\u003cli\u003e| Star Wars What Does the Future Hold for EP.ts\u003c\/li\u003e\n\u003cli\u003e| Sticky Situations for Revascularization in SIHD When the Evidence Is Limited but Opinions Are Vast.ts\u003c\/li\u003e\n\u003cli\u003e| Strategies for Bleeding Avoidance After Complex PCI.ts\u003c\/li\u003e\n\u003cli\u003e| Streamlining diagnosis and treatment in chronic coronary artery disease.ts\u003c\/li\u003e\n\u003cli\u003e| Stress Echo Beyond Obstructive CAD.ts\u003c\/li\u003e\n\u003cli\u003e| Stroke Prophylaxis Treating the Untreated.ts\u003c\/li\u003e\n\u003cli\u003e| Structural Complications \u0026amp; How to Deal with Them.ts\u003c\/li\u003e\n\u003cli\u003e| Structural Heart Disease Challenges in 2021 – Aortic, Mitral and Tricuspid Diseases, Hypertrophic Cardiomyopathies.ts\u003c\/li\u003e\n\u003cli\u003e| Tackling Cardiometabolic Risk A Case Based Discussion.ts\u003c\/li\u003e\n\u003cli\u003e| The Advanced Heart Failure Therapies of LVAD and Transplant Who, What, When, Where, Why, and How DISCUSSION.ts\u003c\/li\u003e\n\u003cli\u003e| The Advanced Heart Failure Therapies of LVAD and Transplant Who, What, When, Where, Why, and HowDIAPOSITIVAS.ts\u003c\/li\u003e\n\u003cli\u003e| The Constant Debate TAVR Versus SAVR – One Size Does Not Fit All.ts\u003c\/li\u003e\n\u003cli\u003e| The European Heart Journal’s Year in Cardiovascular Medicine.ts\u003c\/li\u003e\n\u003cli\u003e| The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand 1.mp4\u003c\/li\u003e\n\u003cli\u003e| The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand 2.mp4\u003c\/li\u003e\n\u003cli\u003e| The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand 4.mp4\u003c\/li\u003e\n\u003cli\u003e| The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand 5.mp4\u003c\/li\u003e\n\u003cli\u003e| The Evolving Lipids Landscape Current and Emerging Nonstatins Meeting on Demand3.mp4\u003c\/li\u003e\n\u003cli\u003e| The Future of Dyslipidemia Management.ts\u003c\/li\u003e\n\u003cli\u003e| The TeleHealth Cardiac Team Challenges and Opportunities.ts\u003c\/li\u003e\n\u003cli\u003e| The Time Has Come For Systematic Screening For Asymptomatic Atrial Fibrillation.ts\u003c\/li\u003e\n\u003cli\u003e| The US-China Consensus on High Efficiency PVI Using RF Energy in Patients with Paroxysmal AF and AF Workflow Sharing.ts\u003c\/li\u003e\n\u003cli\u003e| Thrombosis \u0026amp; Prevention in COVID-19 What Are We Missing.ts\u003c\/li\u003e\n\u003cli\u003e| To Right a Wrong in Heart Failure.ts\u003c\/li\u003e\n\u003cli\u003e| Top Indications for Cardiovascular Magnetic Resonance in Modern Cardiology.ts\u003c\/li\u003e\n\u003cli\u003e| Topical Topics in Pulmonary Arterial Hypertension.ts\u003c\/li\u003e\n\u003cli\u003e| Tough Choices Cases in Cardiogenic Shock.ts\u003c\/li\u003e\n\u003cli\u003e| Tracking the CV Impact of SGLT2i Practice Essentials Meeting on Demand 1.mp4\u003c\/li\u003e\n\u003cli\u003e| Tracking the CV Impact of SGLT2i Practice Essentials Meeting on Demand 2.mp4\u003c\/li\u003e\n\u003cli\u003e| Tracking the CV Impact of SGLT2i Practice Essentials Meeting on Demand 3.mp4\u003c\/li\u003e\n\u003cli\u003e| Tracking the CV Impact of SGLT2i Practice Essentials Meeting on Demand 4.mp4\u003c\/li\u003e\n\u003cli\u003e| Transcatheter Mitral Valve Replacement Expanding Indications and Trial Update.ts\u003c\/li\u003e\n\u003cli\u003e| Translational Cardiac Anatomy.ts\u003c\/li\u003e\n\u003cli\u003e| Treat the Pump or Treat the Rhythm Let’s Talk About Both.ts\u003c\/li\u003e\n\u003cli\u003e| Treating Comorbidities to Treat Heart Failure Sleep, Exercise, Weight Loss, Iron and More.ts\u003c\/li\u003e\n\u003cli\u003e| Tricuspid Regurgitation No Longer The Forgotten Valve.ts\u003c\/li\u003e\n\u003cli\u003e| Under the Bright Light Debates in Interventional Cardiology.ts\u003c\/li\u003e\n\u003cli\u003e| Understanding the Impact of Lp(a) in ASCVD A focus on added CV risk, guidelines, and testing.ts\u003c\/li\u003e\n\u003cli\u003e| Unfolding the Mysteries of Cardiac Amyloidosis.ts\u003c\/li\u003e\n\u003cli\u003e| Uniquely Bicuspid Valve Two Leaflets and A Tool Kit.ts\u003c\/li\u003e\n\u003cli\u003e| Universal Definition of Heart Failure.ts\u003c\/li\u003e\n\u003cli\u003e| Updates in Management of Hypertrophic Cardiomyopathy.ts\u003c\/li\u003e\n\u003cli\u003e| Use of Direct Oral Anticoagulants in Special Populations Complex Dosing Strategies and Complicated Patients.ts\u003c\/li\u003e\n\u003cli\u003e| Valvular Conundrums Grey Area Cases, What the Experts Think.ts\u003c\/li\u003e\n\u003cli\u003e| VASCEPA® (icosapent ethyl) Elevating the Standard of Care.ts\u003c\/li\u003e\n\u003cli\u003e| Vascular Manifestations of COVID-19 Around the Globe.ts\u003c\/li\u003e\n\u003cli\u003e| Vasculo-Oncology Lessons Learned for Clinical Practice in 2021.ts\u003c\/li\u003e\n\u003cli\u003e| Venous Interventions 2021.ts\u003c\/li\u003e\n\u003cli\u003e| Venous Thromboembolism Current Controversies and Practical Management.ts\u003c\/li\u003e\n\u003cli\u003e| Virtual Outpatient Experience for Cardiac Electrophysiologists High Yield Topics.ts\u003c\/li\u003e\n\u003cli\u003e| Vulnerable Plaques Intervention or Pharmacologic Therapy.ts\u003c\/li\u003e\n\u003cli\u003e| Watchman Transmission.ts\u003c\/li\u003e\n\u003cli\u003e| What Can We Learn From Each Other For Global Heart Failure Care.ts\u003c\/li\u003e\n\u003cli\u003e| What You Don’t Know Can’t Help Them – Remote Management of Patients Using Wearables.ts\u003c\/li\u003e\n\u003cli\u003e| What’s In a Name Practicalities of the 4th Universal Definition of MI.ts\u003c\/li\u003e\n\u003cli\u003e| What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 1.mp4\u003c\/li\u003e\n\u003cli\u003e| What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 2.mp4\u003c\/li\u003e\n\u003cli\u003e| What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 3.mp4\u003c\/li\u003e\n\u003cli\u003e| What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 4.mp4\u003c\/li\u003e\n\u003cli\u003e| What’s New in HF Pharmacotherapies The What, How, and Wow Meeting on Demand 5.mp4\u003c\/li\u003e\n\u003cli\u003e| When Fat Overpowers Muscle Obesity and the HFpEF Epidemic.ts\u003c\/li\u003e\n\u003cli\u003e| Working Together to Improve Pediatric and Congenital Heart Disease Care Around the World 5.ts\u003c\/li\u003e\n\u003cli\u003e| World Heart Federation Featured Research With Year in Review.ts\u003c\/li\u003e\n\u003cli\u003e| Yes, No, Maybe How to Diagnose and Treat INOCA (Ischemia and No Obstructive Coronary Artery Disease) Today.ts\u003c\/li\u003e\n\u003cli\u003e| Your PVI Toolkit.ts\u003c\/li\u003e\n\u003cli\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954292789346,"sku":"MED-AMB00458","price":50.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/ACC.21-Congress-American-College-of-Cardiology-2021-Congress-Videos.jpg?v=1779370275","url":"https:\/\/meducourse.com\/products\/acc-21-congress-american-college","provider":"Meducourse","version":"1.0","type":"link"}